Trial watch: Dendritic cell-based anticancer therapy

The use of patient-derived dendritic cells (DCs) as a means to elicit therapeutically relevant immune responses in cancer patients has been extensively investigated throughout the past decade. In this context, DCs are generally expanded, exposed to autologous tumor cell lysates or loaded with specif...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncoimmunology
Autors principals: Bloy, Norma, Pol, Jonathan, Aranda, Fernando, Eggermont, Alexander, Cremer, Isabelle, Fridman, Wolf Hervé, Fučíková, Jitka, Galon, Jérôme, Tartour, Eric, Spisek, Radek, Dhodapkar, Madhav V., Zitvogel, Laurence, Kroemer, Guido, Galluzzi, Lorenzo
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2014
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4292311/
https://ncbi.nlm.nih.gov/pubmed/25941593
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21624011.2014.963424
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars